SIRT1 and hepatocellular carcinoma: Contrary to our observations, Liang et al. [14] have demonstrated increased SIRT1 expression in acquired cisplatin resistant human adenocarcinoma KB-3-1 cells and human hepatoma BEL7404 cells.